Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib maintenance in advanced ovarian cancer (PRIME)
NCT03709316Phase 3Unknown
- Sponsor
- Zai Lab
- Start
- Jun 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of niraparib in ovarian cancer, sponsored by Zai Lab. Status: unknown.
02
Drugs
niraparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03709316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03709316.